COVID-19 Clinical Trials in Phoenix

Showing 21-40 of 75 trials

Back to ECE Safely With SAGE: Reducing COVID-19 Transmission in Hispanic and Low-income Preschoolers

NCT05178290

This study aims to get children safely back to school by (1) Child and Family Testing, (2) ECE Personnel Testing, and (3) Outdoor Learning via Garden Education.

COVID-19 TestingChildren, PreschoolParents+4 more

Arizona State University1,356 participantsStarted Nov 2021

Phoenix, Arizona, United States

COMPLETEDNA< 1 mile

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

NCT05817045

This is a randomized, double-blind, sham controlled, stratified, pivotal efficacy and safety study of the EmitBio RD-X19 treatment device in Individuals 40 Years of age and older with Mild COVID-19 in the at-home setting.

COVID-19

EmitBio Inc.330 participantsStarted Apr 2023

Mesa, Arizona, United States • Phoenix, Arizona, United States • Anaheim, California, United States +45 more locations

Back to ECE Safely With SAGE: Reducing COVID-19 Transmission in Hispanic and Low-income Preschoolers

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

COVID-19 Trials in Other Cities

COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.

Novel Experimental COVID-19 Therapies Affecting Host Response

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older

A Study of Ad26.COV2.S in Adults (COVID-19)

Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19

A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19

A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients

COVID-19 Vaccine Response in Sickle Cell Disease

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities

Other Conditions in Phoenix